tiprankstipranks
Advertisement
Advertisement

ONCY Stock Latest News

Oncolytics Biotech gains FDA Fast Track for pelareorep
Company AnnouncementsOncolytics Biotech gains FDA Fast Track for pelareorep
19h ago
8K
ONCY
Oncolytics announces FDA Fast Track designation for pelareorep
PremiumThe Fly
Oncolytics announces FDA Fast Track designation for pelareorep
20h ago
ONCY
Oncolytics Biotech advances REO 033 colorectal cancer program
PremiumCompany Announcements
Oncolytics Biotech advances REO 033 colorectal cancer program
8d ago
8K
ONCY
Oncolytics provides clinical, regulatory update on REO 033
PremiumThe Fly
Oncolytics provides clinical, regulatory update on REO 033
8d ago
ONCY
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
PremiumCompany Announcements
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
1M ago
8K
ONCY
Oncolytics secures new patent for pelareorep manufacturing
PremiumThe FlyOncolytics secures new patent for pelareorep manufacturing
1M ago
ONCY
Oncolytics promotes John McAdory to COO
Premium
The Fly
Oncolytics promotes John McAdory to COO
2M ago
CGON
ONCY
Oncolytics Biotech Strengthens Leadership with New COO, Director
Premium
Company Announcements
Oncolytics Biotech Strengthens Leadership with New COO, Director
2M ago
8K
ONCY
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
PremiumCompany Announcements
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
2M ago
8K
ONCY
Oncolytics announces initial data from pelareorep combination study
PremiumThe Fly
Oncolytics announces initial data from pelareorep combination study
2M ago
ONCY
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
PremiumThe Fly
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
2M ago
ONCY
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
PremiumCompany Announcements
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
2M ago
8K
ONCY
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
PremiumRatingsJason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
2M ago
ONCY
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
Premium
Company Announcements
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
3M ago
8K
ONCY
Oncolytics says in alignment with FDA following pelareorep Type C meeting
Premium
The Fly
Oncolytics says in alignment with FDA following pelareorep Type C meeting
3M ago
ONCY
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
PremiumCompany Announcements
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
3M ago
8K
ONCY
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
PremiumRatings
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
3M ago
ONCY
Oncolytics price target lowered to $5 from $7 at Lake Street
PremiumThe Fly
Oncolytics price target lowered to $5 from $7 at Lake Street
3M ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
PremiumCompany Announcements
Oncolytics Biotech Establishes $75 Million ATM Offering
4M ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
PremiumCompany AnnouncementsOncolytics Plans FDA Meeting for Pelareorep SCAC Study
4M ago
8K
ONCY
Oncolytics schedules FDA meeting for pelareorep registrational path
Premium
The Fly
Oncolytics schedules FDA meeting for pelareorep registrational path
4M ago
ONCY
Oncolytics Biotech Completes Domestication to Nevada with New Governance
Premium
Company Announcements
Oncolytics Biotech Completes Domestication to Nevada with New Governance
4M ago
8K
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >